Worldwide Life Science Analytics Industry to 2029 - Increasing Acceptance of Analytics Solutions in Clinical Trials is Driving Growth - ResearchAndMarkets.com

23 Nov 2022
www.businesswire.com
DUBLIN--(BUSINESS WIRE)--The "Life Science Analytics Market Analysis by Component, by Type, by Application, by Delivery, by End User by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
'Life Science Analytics Market Analysis by Component, by Type, by Application, by Delivery, by End User by Region - Global Forecast to 2029'
The life science analytics market size is estimated to be USD 24.6 billion in 2021 and is expected to witness a CAGR of 15.31% during the forecast period 2022-2029.
Technological advancements, data storage in the life sciences industry, increasing acceptance of analytics solutions in clinical trials, rising adoption of analytics for sales and marketing applications, and demand for improved data standardisation are some of the major factors that boosts global market growth.
Also, rising incidence of chronic diseases, mounting pressure to reduce healthcare spending, and the need for improved patient outcomes are other factors that propelling the growth during the forecast period. However, high implementation cost hindering the market growth.
Companies Mentioned
Accenture (Ireland)
IQVIA (US)
Wipro (India)
Cognizant (US)
Allscripts Healthcare Solutions (US)
Infosys Limited (US)
MaxisIT (US)
Optum (US)
Cotiviti (US)
This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including component, type, application, delivery, and end user from 2021 to 2029.
Segmentation: Life Science Analytics Market Report 2021-2029
By Component (Revenue, USD Billion)
Software
Services
By Type (Revenue, USD Billion)
Descriptive
Reporting
Prescriptive
Predictive
By Application (Revenue, USD Billion)
Sales & Marketing Support
Supply Chain Analytics
Pharmacovigilance
Regulatory Compliance
By Delivery (Revenue, USD Billion)
On-premises
On-demand
By End User (Revenue, USD Billion)
Biotechnology
Pharmaceutical
Others
By Region (Revenue, USD Billion)
North America
U.S
Canada
Europe
Germany
France
UK
Spain
Italy
Rest of Europe
China
Japan
India
Australia
South Korea
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
Middle East & Africa
South Africa
GCC
Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/85btx1
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.